Vaishali Pharma Limited Market Cap ($9.58 Million)
Market Cap & Net Worth: Vaishali Pharma Limited (VAISHALI)
Vaishali Pharma Limited market cap. Vaishali Pharma Limited (NSE:VAISHALI) has a market capitalization of $9.58 Million (Rs885.84 Million) as of November 4, 2026. Listed on the NSE stock exchange, this India-based company holds position #27048 globally and #1502 in its home market, demonstrating a -0.88% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Vaishali Pharma Limited's stock price Rs6.79 by its total outstanding shares 130462130 (130.46 Million). Also see cash flow conversion of Vaishali Pharma Limited for how efficiently the company converts equity into cash flow.
Vaishali Pharma Limited Market Cap History (2017–2026)
Vaishali Pharma Limited market cap history from 2017 to 2026. Data shows change from $8.54 Million to $9.58 Million (-2.77% CAGR). Check today's stock price for Vaishali Pharma Limited for real-time trading data and today's change.
Vaishali Pharma Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Vaishali Pharma Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore VAISHALI net assets growth trend to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.01x
Vaishali Pharma Limited's market cap is 0.01 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.23x
Vaishali Pharma Limited's market cap is 0.23 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $8.54 Million | $660.55 Million | $6.64 Million | 0.01x | 1.29x |
| 2018 | $9.02 Million | $654.98 Million | $7.98 Million | 0.01x | 1.13x |
| 2019 | $9.17 Million | $724.56 Million | $7.14 Million | 0.01x | 1.29x |
| 2020 | $19.77 Million | $584.11 Million | $327.84K | 0.03x | 60.29x |
| 2021 | $10.12 Million | $537.74 Million | $10.46 Million | 0.02x | 0.97x |
| 2022 | $39.12 Million | $758.21 Million | $40.24 Million | 0.05x | 0.97x |
| 2023 | $51.34 Million | $696.63 Million | $66.03 Million | 0.07x | 0.78x |
| 2024 | $24.68 Million | $862.80 Million | $7.19 Million | 0.03x | 3.43x |
| 2025 | $12.16 Million | $990.26 Million | $8.17 Million | 0.01x | 1.49x |
| 2026 | $9.58 Million | $1.09 Billion | $41.65 Million | 0.01x | 0.23x |
Competitor Companies of VAISHALI by Market Capitalization
Companies near Vaishali Pharma Limited in the global market cap rankings as of November 4, 2026. Also see balance sheet size of Vaishali Pharma Limited for a full breakdown of the balance sheet.
Key companies related to Vaishali Pharma Limited by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #509 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #534 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #580 globally with a market cap of $46.03 Billion USD ( CN¥314.55 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #618 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #509 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #534 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $45.90 |
| #580 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $46.03 Billion | CN¥49.31 |
| #618 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.50 |
Market Capitalization of Vaishali Pharma Limited (2017–2026)
Market capitalization of Vaishali Pharma Limited from 2017 to today. Between 2017 and today, Vaishali Pharma Limited's market cap moved from $8.54 Million to $ 9.58 Million, with a yearly change of -2.77%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs9.58 Million | -21.23% |
| 2025 | Rs12.16 Million | -50.71% |
| 2024 | Rs24.68 Million | -51.94% |
| 2023 | Rs51.34 Million | +31.23% |
| 2022 | Rs39.12 Million | +286.75% |
| 2021 | Rs10.12 Million | -48.82% |
| 2020 | Rs19.77 Million | +115.54% |
| 2019 | Rs9.17 Million | +1.72% |
| 2018 | Rs9.02 Million | +5.62% |
| 2017 | Rs8.54 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Vaishali Pharma Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $9.58 Million USD |
| MoneyControl | $9.58 Million USD |
| MarketWatch | $9.58 Million USD |
| marketcap.company | $9.58 Million USD |
| Reuters | $9.58 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Vaishali Pharma Limited
Vaishali Pharma Limited engages in the pharmaceutical business in India and internationally. It offers a portfolio of active pharmaceutical ingredients, such as antibiotics, anti-ulcer, anti-inflammatory, analgesic, anti-pyretic, topical steroids, anti"malarial, cardiac, corticosteroids, anti-diabetics, anti-cold, anti-allergic, anti-diarrheal, anti-protozoal, anti-parasitic, excipients, anti-vir… Read more